These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 8808165

  • 1. Natural vs synthetic surfactants in neonatal respiratory distress syndrome.
    Halliday HL.
    Drugs; 1996 Feb; 51(2):226-37. PubMed ID: 8808165
    [Abstract] [Full Text] [Related]

  • 2. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
    Moya FR, Gadzinowski J, Bancalari E, Salinas V, Kopelman B, Bancalari A, Kornacka MK, Merritt TA, Segal R, Schaber CJ, Tsai H, Massaro J, d'Agostino R, International Surfaxin Collaborative Study Group.
    Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380
    [Abstract] [Full Text] [Related]

  • 3. Calfactant: a review of its use in neonatal respiratory distress syndrome.
    Onrust SV, Dooley M, Goa KL.
    Paediatr Drugs; 1999 Apr; 1(3):219-43. PubMed ID: 10937453
    [Abstract] [Full Text] [Related]

  • 4. Overview of clinical trials comparing natural and synthetic surfactants.
    Halliday HL.
    Biol Neonate; 1995 Apr; 67 Suppl 1():32-47. PubMed ID: 7647157
    [Abstract] [Full Text] [Related]

  • 5. Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.
    Dechant KL, Faulds D.
    Drugs; 1991 Nov; 42(5):877-94. PubMed ID: 1723378
    [Abstract] [Full Text] [Related]

  • 6. Exogenous surfactant use in neonates.
    Ishisaka DY.
    Ann Pharmacother; 1996 Apr; 30(4):389-98. PubMed ID: 8729894
    [Abstract] [Full Text] [Related]

  • 7. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
    Hudak ML, Martin DJ, Egan EA, Matteson EJ, Cummings NJ, Jung AL, Kimberlin LV, Auten RL, Rosenberg AA, Asselin JM, Belcastro MR, Donohue PK, Hamm CR, Jansen RD, Brody AS, Riddlesberger MM, Montgomery P.
    Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
    [Abstract] [Full Text] [Related]

  • 8. A risk-benefit assessment of natural and synthetic exogenous surfactants in the management of neonatal respiratory distress syndrome.
    Walti H, Monset-Couchard M.
    Drug Saf; 1998 May; 18(5):321-37. PubMed ID: 9589844
    [Abstract] [Full Text] [Related]

  • 9. Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome.
    Bloom BT, Kattwinkel J, Hall RT, Delmore PM, Egan EA, Trout JR, Malloy MH, Brown DR, Holzman IR, Coghill CH, Carlo WA, Pramanik AK, McCaffree MA, Toubas PL, Laudert S, Gratny LL, Weatherstone KB, Seguin JH, Willett LD, Gutcher GR, Mueller DH, Topper WH.
    Pediatrics; 1997 Jul; 100(1):31-8. PubMed ID: 9200357
    [Abstract] [Full Text] [Related]

  • 10. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F, Sinha S, Gadzinowski J, D'Agostino R, Segal R, Guardia C, Mazela J, Liu G, SELECT and STAR Study Investigators.
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [Abstract] [Full Text] [Related]

  • 11. Controversies: synthetic or natural surfactant. The case for natural surfactant.
    Halliday HL.
    J Perinat Med; 1996 Jun; 24(5):417-26. PubMed ID: 8950721
    [Abstract] [Full Text] [Related]

  • 12. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
    Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
    [Abstract] [Full Text] [Related]

  • 13. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
    Yost CC, Soll RF.
    Cochrane Database Syst Rev; 2000 Jan; (2):CD001456. PubMed ID: 10796266
    [Abstract] [Full Text] [Related]

  • 14. Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing country.
    da Costa DE, Pai MG, Al Khusaiby SM.
    Pediatr Pulmonol; 1999 May; 27(5):312-7. PubMed ID: 10344709
    [Abstract] [Full Text] [Related]

  • 15. Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome.
    Wiseman LR, Bryson HM.
    Drugs; 1994 Sep; 48(3):386-403. PubMed ID: 7527760
    [Abstract] [Full Text] [Related]

  • 16. Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials.
    Zhang L, Cao HY, Zhao S, Yuan LJ, Han D, Jiang H, Wu S, Wu HM.
    Pulm Pharmacol Ther; 2015 Oct; 34():46-54. PubMed ID: 26296793
    [Abstract] [Full Text] [Related]

  • 17. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome.
    Soll RF, Blanco F.
    Cochrane Database Syst Rev; 2001 Oct; (2):CD000144. PubMed ID: 11405951
    [Abstract] [Full Text] [Related]

  • 18. Colfosceril palmitate. A pharmacoeconomic evaluation of a synthetic surfactant preparation (Exosurf Neonatal) in infants with respiratory distress syndrome.
    Bryson HM, Whittington R.
    Pharmacoeconomics; 1994 Dec; 6(6):563-77. PubMed ID: 10155285
    [Abstract] [Full Text] [Related]

  • 19. Protein-containing synthetic surfactant versus protein-free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.
    Pfister RH, Soll R, Wiswell TE.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD006180. PubMed ID: 19821357
    [Abstract] [Full Text] [Related]

  • 20. Lung surfactants.
    Ghodrat M.
    Am J Health Syst Pharm; 2006 Aug 15; 63(16):1504-21. PubMed ID: 16896079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.